Market Overview

The global nicotine gum market size was valued at USD 1.63 billion in 2023 and is projected to grow from USD 1.70 billion in 2024 to USD 2.55 billion by 2032, exhibiting a CAGR of 5.1% during the forecast period (2024-2032).

Rising health awareness and prevalence of illnesses are expected to enhance the market growth. Fortune Business Insights™ presents this information in its report titled “Nicotine Gum Market, 2024-2032.”

Segmentation

2MG Segment to Dominate Owing to its Easy Availability

By product type, the market is segmented into 2mg, 4mg, and 6mg.

The 6mg segment is expected to dominate due to its easy availability. The product's availability in several flavors may attract potential consumers, thereby boosting market progress. It reduces craving and nicotine withdrawal capability.

Pharmaceutical Sector to Dominate Owing to Consumer Preferences for Purchasing in Nearby Stores

By distributional channel, it is classified into supermarkets and hypermarkets, pharmacies, and online

The pharmacies segment is expected to dominate the market due to the assurance of consumer trust and product standards. Marketing and sales of these products may increase due to well-trained pharmaceuticals and general practitioners.

Regionally, the market is classified into North America, Europe, Asia Pacific, South America, and the Middle East & Africa.

Source: https://www.fortunebusinessinsights.com/nicotine-gum-market-106655

Report Coverage

The report provides a detailed look at the main parts of the beef market and the latest trends. It examines what is helping the market grow and what is holding it back, including the impact of COVID-19. Additionally, it covers developments in different regions and the tactics used by major companies in the industry.

Driving Factors

Anti-Smoking Campaign Promotions to Facilitate Market Progress

Nicotine gum, which helps people quit smoking by reducing cravings, is used every two hours. Research and development, along with support from government and non-government organizations, are expected to increase demand for the product. Companies are also focusing on anti-smoking campaigns and introducing new products like lozenges and gums to help combat cravings. Additionally, the rise in smoking-related illnesses, such as lung cancer, is likely to boost demand for nicotine gum, potentially leading to market growth.

However, the side effects of nicotine gum are likely to impede market growth in the coming years.

Regional Insights

Rising Number of Health Conscious Consumers to Propel Market Growth in North America

North America is expected to dominate the nicotine gum market share due to increasing health-conscious consumers. The market in North America stood at USD 650.47 in 2022 and is expected to gain huge market share in the upcoming years. Furthermore, major brands focus on launching innovative products to enhance their quality and boost brand image globally.

In Europe, the rising nicotine gum product sales in France, Italy, Germany, and the U.K. are expected to enhance the demand for nicotine gums. Furthermore, a strong focus on implementing strategies for quitting smoking is expected to enhance demand.

In Asia Pacific, strong demand for innovative products, is expected to enhance the demand for the product. Furthermore, the rising demand for innovative products and increasing competition between companies are expected to enhance the market growth.

Competitive Landscape

Major Players Launch Novel Products to Reinforce Brand Presence

The prominent companies operating in the market announce novel products to reinforce their brand image globally. For example, Nicorette announced a nicotine gum with ice mint lozenge in May 2019. This product offers a smooth texture and provides a punch of mint flavor. This launch may enable the company to attract consumers and enhance its brand presence globally. Furthermore, companies devise acquisitions, mergers, partnerships, and expansion strategies to enhance their market position.

Key Industry Development

• July 2021: Philip Morris International acquired Fertin Pharma, a developer and producer of well-being and pharmaceutical products based on intra-oral and oral delivery systems.

List of Key Players Profiled in the Nicotine Gum Market Report

• GlaxoSmithKline plc (U.K.)
• Johnson & Johnson (S.)
• Novartis Consumer Health (Germany)
• ITC Limited (India)
• Cipla Health Limited (India)
• Perrigo Company Plc (Ireland)
• Fertin Pharma (Denmark)
• Alchem International (India)
• Revolymer (U.K.)